Details of the Drug Reposition

General Information of This Drug (ID: DMEDF2B)

Drug Name
Adcetris   DMEDF2B

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
T-cell leukaemia DISJ6YIF 2A90 Phase 3 [1]
Cutaneous T-cell lymphoma DISAYSZB 2B01 Phase 3 [1]
Hodgkin lymphoma DISX2OUL 2B30 Phase 3 [2]
------------------------------------------------------------------------------------
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 2 [1]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)